CN Patent

CN111620854A — 4-氨基嘧啶取代的苯基酰胺类化合物及其制备方法

Assigned to Shanghai Xinshengyuan Pharmaceutical Co ltd · Expires 2020-09-04 · 6y expired

What this patent protects

本发明公开了一种4‑氨基嘧啶取代的苯基酰胺类化合物及其制备方法。本发明的4‑氨基嘧啶取代的苯基酰胺类化合物的结构为式I所示。本发明的4‑氨基嘧啶取代的苯基酰胺类化合物对正常细胞毒性较小，对EGFR突变株具有较好的选择性。

USPTO Abstract

本发明公开了一种4‑氨基嘧啶取代的苯基酰胺类化合物及其制备方法。本发明的4‑氨基嘧啶取代的苯基酰胺类化合物的结构为式I所示。本发明的4‑氨基嘧啶取代的苯基酰胺类化合物对正常细胞毒性较小，对EGFR突变株具有较好的选择性。

Drugs covered by this patent

Patent Metadata

Patent number
CN111620854A
Jurisdiction
CN
Classification
—
Expires
2020-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Xinshengyuan Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.